CD4 and leishmaniasis: AVL-HIV/AIDS patients in clinical remission showed significantly (p < 0.001) lower numbers of CD4+ T lymphocytes in comparison to HIV-1 infected patients without leishmaniasis, (Figure 1A and Table 1).